ION Geophysical Corporation IO
Apr 24, 2025, 3:47 PM EDT
52-week range unavailable
- Revenue (ttm)
- 105.44M
- Profit margin
- -42.05%
- Shares out
- 29.58M
- Forward P/E
- -1.23
- Volume
- 904.58K
- Open
- 0.3592
- Previous close
- 0.345
- Day's range
- 0.33 – 0.369
- Beta
- 3.27
- Analysts
- Hold
- Price target
- 1.50 (+334.8%)
- Earnings date
- May 25, 2022
2Y -4.9350 (-93.47%)
Key statistics
- Enterprise value
- 166.15M
- PEG ratio
- 0.00
- Price / sales
- 0.10
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 173.40%
- Free cash flow
- -35.52M
- Total cash
- 24.14M
- Total debt
- 174.60M
- Return on equity
- 0.00%
- Short % of float
- 20.53%
- 50-day average
- 0.596286
- 200-day average
- 1.08
Analyst view
Consensus: hold
- Strong buy0
- Buy0
- Hold1
- Sell0
- Strong sell0
Next earnings
May 25, 2022
Expected May 25, 2022. Consensus EPS estimate 0.04.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| May 25, 2022 | Mar 1, 2022 | 0.00 | — | — | — |
| Apr 6, 2022 | Dec 1, 2021 | -0.38 | — | — | — |
| Nov 3, 2021 | Sep 1, 2021 | -0.02 | — | — | — |
| Aug 11, 2021 | Jun 1, 2021 | -0.24 | — | — | — |
| May 5, 2021 | Mar 1, 2021 | -0.61 | — | — | — |
| Feb 10, 2021 | Dec 1, 2020 | -0.54 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Apr 26, 2022 | Alliance Global Partners | down | Buy | Sell |
| Jun 2, 2021 | Alliance Global Partners | init | — | Buy |
| Feb 16, 2021 | HC Wainwright & Co. | main | — | Buy |
| Jul 22, 2020 | HC Wainwright & Co. | init | — | Buy |
| Nov 2, 2018 | Oppenheimer | down | Outperform | Perform |
| May 29, 2018 | Janney Capital | init | — | Buy |
About ION Geophysical Corporation
ION Geophysical Corporation provides data-driven decision-making to offshore energy, and ports, and defense industries worldwide. The company operates through two segments, E&P Technology & Services and Operations Optimization. The E&P Technology & Services segment creates digital data assets and delivers services to help E&P companies improve decision-making and reduce risk. This segment includes two synergistic groups, imaging and reservoir services, and ventures. The company's Imaging and Reservoir Services group provides data processing, imaging, and reservoir services that improve image quality and subsurface insights, helping E&P companies reduce exploration and production risk, evaluate and develop reservoirs, and increase production. Its Imaging and Reservoir Services group develops and applies proprietary processing algorithms through its imaging engine to data owned or licensed by its customers to translate raw data into subsurface images. The Operations Optimization segment develops mission-critical subscription offerings and provides engineering services that enable operational control and optimization offshore. This segment includes the company's Optimization Software & Services and Devices offerings. The company's Optimization Software & Services group provides survey design, command, and control software systems and related services for marine towed streamer and seabed operations. Its Devices offerings group develops intelligent equipment controlled by its software to optimize operations. The company sells its services and products through a direct sales force consisting of employees and international third-party sales representatives. ION Geophysical Corporation was formerly known as Input/Output, Inc. and changed its name to ION Geophysical Corporation in 2007. The company was founded in 1968 and is headquartered in Houston, Texas. On April 12, 2022, ION Geophysical Corporation along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of Texas.
- Sector
- Energy
- Industry
- Oil & Gas Equipment & Services
- Country
- United States
- Website
- iongeo.com
News
IMFINZI® (durvalumab) plus tarlatamab-dlle reduced the risk of death by 58% in 1st-line extensive-stage small cell lung cancer in the DeLLphi-305 Phase III trial 
Perioperative IMFINZI® (durvalumab) plus neoadjuvant enfortumab vedotin reduced risk of recurrence by 49% and risk of death by 42% in muscle-invasive bladder cancer 
Innovent Announces First Patient Dosed in Pivotal Registrational Study of IBI363/TAK-928 (PD-1/IL-2α-biased Bispecific Fusion Protein) in Combination with Bevacizumab in Late-Line Advanced Colorectal 
IMFINZI® (durvalumab) approved in the US in first and only immunotherapy combination for patients with BCG-naïve, high-risk non-muscle-invasive bladder cancer 
IMFINZI® (durvalumab) granted Priority Review in the US for patients with muscle-invasive bladder cancer 
IMFINZI® (durvalumab) demonstrated statistically significant and clinically meaningful improvement in event-free survival and overall survival for muscle-invasive bladder cancer in NIAGARA Phase III trial 
IMFINZI® (durvalumab) significantly improved overall survival and progression-free survival for patients with limited-stage small cell lung cancer in ADRIATIC Phase III trial 
Stocks That Hit 52-Week Lows On Wednesday 
62 Biggest Movers From Yesterday 
Top Reddit Penny Stocks in 2022? Check These 3 Out For Your List
Your note
Sign in to keep a note on IO — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| DORAN MARK J | Director | Stock Award(Grant) | Feb 28, 2022 | 4,711 |
| GATES CAPITAL MANAGEMENT, INC. | Beneficial Owner of more than 10% of a Class of Security | Sale | Sep 22, 2021 | 0 |
| LAPEYRE JAMES M JR | Director | Stock Award(Grant) | Feb 28, 2022 | 1,639,850 |
| MCGOVERN MICHAEL Y | Director | Stock Award(Grant) | Feb 28, 2022 | 9,793 |
| MORRISON MICHAEL L | Chief Financial Officer | Stock Award(Grant) | May 10, 2021 | 129,971 |
| NELSON S JAMES JR | Director | Stock Award(Grant) | Feb 28, 2022 | 26,766 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Gates Capital Management, Inc. | 9.02% | 2,672,096 | 2.35M | Dec 30, 2021 |
| Vanguard Group, Inc. (The) | 3.41% | 1,009,992 | 880.71K | Mar 30, 2022 |
| Neuberger Berman Group, LLC | 0.83% | 245,442 | 214.03K | Mar 30, 2022 |
| Renaissance Technologies, LLC | 0.78% | 232,053 | 202.35K | Mar 30, 2022 |
| Blackrock Inc. | 0.69% | 203,401 | 177.37K | Mar 30, 2022 |
| Geode Capital Management, LLC | 0.65% | 193,457 | 168.69K | Mar 30, 2022 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.08% | 615,545 | 541.68K | Dec 30, 2021 |
| Vanguard Extended Market Index Fund | 0.95% | 281,112 | 247.38K | Dec 30, 2021 |
| Fidelity Extended Market Index Fund | 0.48% | 141,493 | 82.21K | Feb 27, 2022 |
| Neuberger & Berman Intrinsic Value Fd | 0.39% | 115,600 | 67.16K | Feb 27, 2022 |
| MSS Ser Tr-Footprints Discover Value Fd | 0.37% | 108,270 | 62.90K | Feb 27, 2022 |
| Bridgeway Funds Inc-Ultra Small Company Market Fund | 0.30% | 90,000 | 79.20K | Dec 30, 2021 |